EMT is now an established molecular pathway involved in melanoma progression, recognized also as an important therapeutic target, and our array analysis identified a number of EMT-regulatory genes responsive to GLO1 status implicated mechanistically in metastatic melanoma [13,25,26,27,28,29,30,31,32,33,34]. The gene discussed is GLO1; the disease is metastatic melanoma.